We are developing technology that will make diagnostics as simple as taking a pregnancy test
Platform technology allows for immediate treatment decisions to be taken at point-of-care, economically and without the need for centralised laboratory based testing
Rapid handheld point-of-care liquid bippsy diagnostic platform
Patented platform amplification technology allows rapid nucleic acid detection from blood in an economica and simple-to-use format, whenever and wherever you want
Cancer companion diagnostics
Allowing immediate clinical decisions to be taken during a single out-patient appointment- anywhere you wish
Enabling detection technology to rapidly detect infectious disease in a simple blood test, wherever you want without the need for hospitals or clinics. Cheaply and easily.
Recently, the online newspaper of economic information specialized in the business of health in Spain; PlantaDoce, has made an article about Indicate Solutions. Do not miss it! https://www.plantadoce.com/empresa/indicate-solutions-a-la-caza-de-800000-euros-para-lanzar-su-test-de-diagnostico-de-cancer.html
Indicate solutions has been selected to access the Bridge for MassChallenge where it will be part of a Bootcamp in the famous Accelerator. After this week, a Pitch Competition will be held to select the 4 best companies. We hope to get it!
Recently, Indicate Solutions has been selected to access Ship2b’s Tech4Health accelerator to prepare to validate the market and access Investor rounds. We hope we find it useful!
Last sunday the 3th was the race for the rare illnesses called “Carrera por la Esperanza” and Javier Zubiria, our Business Development Manager was there. We hope in the future Indicate can contribute with our device in such an important field.
The last 21 of february, the King gave our Advisor, Luis Liz Marzan the National Research Award. We wish you enjoy it and many more success in his career!
Just admited in the selection workshop for the LAB Tech4Health the next 6 and 7 of March in Barcelona!
At Indicate Solutions we started 2019 with a lot of enthusiasm and wishes for this new year. We wish you a happy year!
The molecular oncology group of the Institute of Biodonostia, led by our CEO; Charles Lawrie, has managed to be at the forefront of the world in the fight against head and neck cancer thanks to a work in DNA biomarkers for the early detection of carcinoma of the larynx. The key to this work is[…]
Ana joins to Indicate solutions as our new CSO from CIC biomaGUNE. She worked on the development of technology in the CIC biomaGUNE laboratory.
The last 8th of November our CEO, Charles Lawrie, presented Indicate Solutions in the Imagine If competition, organized by the Innovation Forum Euskadi. We did not win, but we left with illusion for the generated expectation.